Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Ullevaal University Hospital Helse Nord |
---|---|
Information provided by: | Ullevaal University Hospital |
ClinicalTrials.gov Identifier: | NCT00572819 |
The aim of this study is to investigate whether 1000 micrograms of self-administered vaginal misoprostol 12 hours before operative hysteroscopy results in effective preoperative cervical ripening after two weeks pretreatment with 25 micrograms daily vaginal estradiol, compared to placebo (lactosum monohydricum) in postmenopausal women.
Condition | Intervention | Phase |
---|---|---|
Cervical Ripening |
Drug: Misoprostol Drug: Placebo |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator), Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | Does Self-Administered Vaginal Misoprostol Result in Cervical Ripening in Postmenopausal Women After 14 Days Pre-Treatment With Estradiol? |
Estimated Enrollment: | 100 |
Study Start Date: | January 2008 |
Estimated Study Completion Date: | December 2009 |
Estimated Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Misoprostol: Active Comparator |
Drug: Misoprostol
1000 micrograms of self-administered vaginal misoprostol compared to placebo 12 hours before operative hysteroscopy after two weeks pretreatment with 25 micrograms daily vaginal oestradiol.
|
Placebo: Placebo Comparator |
Drug: Placebo
Vaginal lactosum monohydricum administered 24 hours in postmenopausal women, compared to misoprostol after two weeks pretreatment with 25 micrograms daily vaginal oestradiol.
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Britt-Ingjerd Nesheim, MD, PhD | +4722119813 | bine@ulleval.no |
Contact: Kevin Sunde Oppegaard, MD | +4798644405 | kevinsunde@yahoo.com.sg |
Norway | |
Gynaecological Department, Ullevål University Hospital | Recruiting |
Oslo, Norway, N-0450 | |
Contact: Britt I Nesheim, MD, PhD 4722119800 Britt-Ingjerd.Nesheim@ulleval.no | |
Principal Investigator: Kevin Oppegaard, MD |
Study Chair: | Britt-Ingjerd Nesheim, MD, PhD | University of Oslo, Faculty of Medicine |
Responsible Party: | Gynaecological Department, Ullevål University Hospital, Oslo, Norway ( Britt-Ingjerd Nesheim ) |
Study ID Numbers: | 2007-004083-52, 2007-004083-52 |
Study First Received: | December 12, 2007 |
Last Updated: | November 26, 2008 |
ClinicalTrials.gov Identifier: | NCT00572819 |
Health Authority: | Norway: Norwegian Medicines Agency |
Hysteroscopy Misoprostol Postmenopausal women Cervical ripening |
Dilatation Sequential trial Estradiol |
Dilatation, Pathologic Benzoates Estradiol 3-benzoate Estradiol valerate |
Misoprostol Estradiol 17 beta-cypionate Polyestradiol phosphate Estradiol |
Estrogens Oxytocics Contraceptive Agents Physiological Effects of Drugs Hormones, Hormone Substitutes, and Hormone Antagonists Contraceptive Agents, Female Gastrointestinal Agents |
Reproductive Control Agents Abortifacient Agents, Nonsteroidal Hormones Pharmacologic Actions Therapeutic Uses Abortifacient Agents Anti-Ulcer Agents |